Response to high-dose intravenous immune globulin as a valuable factor predicting the effect of splenectomy in chronic idiopathic thrombocytopenic purpura patients.
Choi CW, Kim BS, Seo JH, Shin SW, Kim YH, Kim JS, Sohn SK, Kim JS, Shin DG, Ryoo HM, Lee KH, Lee JJ, Chung IJ, Kim HJ, Kwak JY, Yim CY, Ahn JS, Lee JA, Park YS.
Choi CW, et al. Among authors: kim yh, kim bs, kim hj, kim js.
Am J Hematol. 2001 Mar;66(3):197-202. doi: 10.1002/1096-8652(200103)66:3<197::aid-ajh1044>3.0.co;2-6.
Am J Hematol. 2001.
PMID: 11279626
Free article.
Clinical Trial.